Cognitive Behavioral Therapy on Adherence and Depression (CBT-AD) Among HIV/AIDS Patients
A Randomized Control Trial of Cognitive Behavioral Therapy on Adherence and Depression (CBT-AD) Among HIV/AIDS Patients on Follow up at Mattu Karl and Bedele Hospital, 2019
1 other identifier
interventional
128
1 country
1
Brief Summary
Depression is highly comorbid with HIV/ AIDS and is associated with worse poor adherence to antiretroviral therapy (ART), and potentially to long-term immune functioning. Cognitive behavioral therapy may solve these problem.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable depression
Started May 2021
Typical duration for not_applicable depression
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2021
CompletedFirst Submitted
Initial submission to the registry
October 17, 2023
CompletedFirst Posted
Study publicly available on registry
October 31, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2023
CompletedOctober 31, 2023
October 1, 2023
2.5 years
October 17, 2023
October 28, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
The mean score of Depression will change after intervention
Depression is measured by Patient Health Questionnaire (PHQ-9) Depression Scale. The minimum value is 0 and the maximum value is 27. The higher score mean worse outcome
Through study completion, an average of 1 yea
Study Arms (2)
Intervention group
EXPERIMENTALTaking Behavioral Therapy
Control group
NO INTERVENTIONDo not taking Behavioral Therapy
Interventions
The treatment will be offered to participants free of charge. Cognitive Behavioral Therapy (CBT) sessions will be delivered in a group therapy format and the sessions will be offered in successive weeks. The protocol will be then administered to the intervention group (in 8 groups over a period of six months, eight sessions, each of 30 minutes' length).
Eligibility Criteria
You may qualify if:
- PLWHA who were 18 years old and above were included in the study
You may not qualify if:
- PLWHA who were previously took CBT and participants with acute physical or mental disturbances were excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mattu Universitylead
Study Sites (1)
Mattu University
Addis Ababa, 318, Ethiopia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Zakir Abdu, MSc
Mattu Universitry
- STUDY CHAIR
Mohammedamin Hajure, MSc
Mattu University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Psychiatry
Study Record Dates
First Submitted
October 17, 2023
First Posted
October 31, 2023
Study Start
May 1, 2021
Primary Completion
November 1, 2023
Study Completion
November 1, 2023
Last Updated
October 31, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will not share
Any qualified researchers could get the data from principal investigator at any time